Delivery Order SPE2DB22D1017-SPE2DB25FG3MH

Award Date 5/27/25
Potential Completion Date 5/28/25
Potential Value $4.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,108,607 units of the biologic medication Cimzia (certolizumab pegol) 2x200 mg/mL syringe kits, with a ceiling value of $25,267.75. The contract is a firm fixed-price, non-set-aside award with a period of performance through May 2, 2025. AmerisourceBergen holds a $999,999,999.00...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $7,854.95, is for the delivery of CIMZIA 2X200 MG/ML syringe kits, a medication used to treat certain medical conditions. The contract has a firm fixed price and an ultimate completion date of April 17, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,567,942,875 units of the medication CIMZIA 2X200 MG/ML SYRINGE KITS, with a ceiling value of $3,911.81. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. The ultimate completion date for this order is April 17, 2025. AmerisourceBergen Drug...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,748,554 units of the medication CIMZIA 2X200 MG/ML SYRINGE KITS, with a ceiling value of $7,061.06 and a period of performance through July 10, 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CIMZIA 2X200 MG/ML syringe kits. The contract has a firm fixed price, non-set-aside designation, and a ceiling value of $6,779.11. The ultimate completion date is May 15, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,851.85 firm-fixed-price contract is for the provision of CIMZIA 2X200 MG/ML syringe kits. This order is under a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $20,181.37, is for the delivery of 4560594952 CIMZIA 2X200 MG/ML syringe kits. The order has an ultimate completion date of April 17, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of CIMZIA 2X200 MG/ML syringe kits. The contract has a firm fixed price, with a ceiling value of $4,649.91, and an ultimate completion date of June 27, 2025. This contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp also holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,451,455 units of CIMZIA 2X200 MG/ML syringe kits, with a firm fixed price of $15,078.48 and a completion date of November 18, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,528,590 units of the drug CIMZIA (certolizumab pegol) 2X200 mg/mL syringe kits, with a ceiling value of $7,061.06 and a completion date of June 13, 2025. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FG3MH
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,568,362,957 units of the drug CIMZIA (certolizumab pegol) 2X200 mg/mL syringe kits. The contract has a firm fixed price of $4,581.58 and a completion date of May 28, 2025. This order is not a set-aside contract. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026 to supply a wide range of medical products to federal agencies, particularly the Defense Health Agency and U.S. Coast Guard.

Generated 8/31/25, 12:58 AM